Advertisement

Losers Fight Back

By Richard P. Grant Losers Fight Back Dr Adam Schindler and Dr David Sherwood (Anchor cell invasion initiates uterine-vulval attachment during C. elegans larval development) The paper M. Portela et al., “Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition,” Dev Cell, 19:562-73, 2010. Free F1000 Evaluation The finding During development and aging, animal cells that have been weakened by mutation, infe

By | February 1, 2011

Losers Fight Back

Dr Adam Schindler and Dr David Sherwood (Anchor cell invasion initiates uterine-vulval attachment during C. elegans larval development)

The paper

M. Portela et al., “Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition,” Dev Cell, 19:562-73, 2010. Free F1000 Evaluation

The finding

During development and aging, animal cells that have been weakened by mutation, infection, and oxidative damage can be forced to commit suicide by signals from healthy cells—a process called competition. But if a cell has suffered only a temporary setback, say a transient transcription error, it can buy time by expressing a survival factor, a protein called SPARC.

The mediator

Eduardo Moreno’s group at the Spanish National Cancer Research Centre in Madrid was looking at cellular competition during Drosophila development when they noticed that SPARC prevented apoptosis in loser cells by inhibiting caspase activation. Moreno quips that SPARC is “a mechanism to solve problems in cellular society”—a sort of community mediator.

The role

”We really still don’t understand: is there one central thing that SPARC does, or are there many different activities?” says F1000 Member David Sherwood. He studied SPARC’s role in cell adhesion in C. elegans, finding that its overexpression promotes cell-invasive activity. But it appears to have multiple roles both in normal development and in cancer.

The next step

A key question now for cell competition is determining the molecular mechanisms. “I’d like to know how SPARC is functioning,” says Sherwood. Moreno plans to investigate how the killing signal is intercepted by SPARC. He also plans to overexpress SPARC in normal human cells to see if it might help them outcompete neighboring tumor cells.

F1000 evaluators: M. Morrissey & D. Sherwood (Duke University) K. Jones & U. Banerjee (UCLA)

Advertisement

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies